michael-muehlegger

Michael Mühlegger

Senior Director Marketing & Inside Sales

Michael Mühlegger is the Head of Marketing and Inside Sales at Single Use Support. He has 10+ years experience in the fields of marketing, inside sales, communications, content management, and creative production. With a keen understanding of market dynamics and customer behavior, Michael has successfully implemented innovative marketing strategies to drive business growth and enhance brand visibility.

He has a strong background in content management, with a focus on life sciences and biopharma trends, and is adept at creating compelling content across multiple platforms to engage audiences and effectively communicate brand messages.

 

Articles written by Michael Mühlegger

Bioconjugates

FDA approved Antibody Drug Conjugates (ADCs)

ADCs offer new, highly promising approaches in the therapy of various cancer types, and the number of approved ADCs is continuously growing. In this article, we will have a look at ADCs currently approved.

michael-muehlegger

Michael Mühlegger

May 7, 2024

Bioconjugates

Bioconjugation simply explained

Bioconjugation is a pharmaceutical technique that is gaining more and more importance, most of all in cancer therapy. In this article, we will provide some basic information on bioconjugation, but also discuss major challenges related to this field.
 

michael-muehlegger

Michael Mühlegger

April 20, 2023

Bioprocessing

Automated bioprocessing – 7 advantages of automation

Automation is affecting various aspects of our lives, including bioprocessing. In this article, we will explore the advantages that come with this development.

michael-muehlegger

Michael Mühlegger

April 12, 2023

Biopharma

Biopharma supply chain – 7 risks to be aware of

The entire biopharma industry depends on intact supply chain in order to provide patients with the drug products they need. However, there are several factors that can put the integrity of supply chain at risk. In this article, we will discuss seven of them and explore what can be done to circumvent them.

michael-muehlegger

Michael Mühlegger

March 29, 2023

Bioprocessing

Microbial cGMP production: complete guide & manufacturer's overview

Microbial fermentation is a hot topic not only in the biopharma industry. In this article, you will find a brief overview of microbial fermentation manufacturing before we discover different CDMOs offering microbial cGMP production.

michael-muehlegger

Michael Mühlegger

March 9, 2023

Biopharma

cGMP - everything you need to know

The current Good Manufacturing Practice (cGMP) regulations - originated and checked by the FDA - apply to companies operating in pharmaceutical, biotech, or med tech industries. They require the latest standards in terms of production, manufacturing, and packaging and thereby ensure pharmaceutical quality meaning quality in manufacturing processes and patient safety as the ultimate goal. The detailed requirements, importance of cGMP, and how companies can best meet the cGMP regulations, are discussed in the following.

michael-muehlegger

Michael Mühlegger

March 1, 2023

Biopharma

CDMO in Biopharma: Opportunity or risk?

Both, CDMOs and CMOs, are offering major opportunities in biopharma for startups and emerging companies as well as for established players who are approaching the limits of their manufacturing facilities or are generally looking to outsource parts of or their entire commercial production. 

michael-muehlegger

Michael Mühlegger

June 16, 2025

News

Innovations for the biopharmaceutical industry made in Tyrol

michael-muehlegger

Michael Mühlegger

June 14, 2022

Cell & Gene Therapy

Gene therapy manufacturing - 5 requirements to scale up

Gene therapies have become a highly promising field of groundbreaking next generation treatment, but there are some challenges to face within the manufacturing process. Here are 5 factors that will be crucial for upscaling gene therapy manufacturing with single-use technology.

michael-muehlegger

Michael Mühlegger

June 9, 2022

Biopharma

Industry 4.0 in Biomanufacturing: RoSS.KSET as an example

Industry 4.0 has long become reality in many branches. In Pharma 4.0 intelligent industrial applications and IoT enable players in the bioeconomy industry  to transition to operations that help them improve their productivity. Pharma 4.0 also has become a major part in single-use technologies, as it brings companies to the next level concerning the scalability, productivity and efficiency of their processes and products. 

michael-muehlegger

Michael Mühlegger

May 18, 2022

Single-use Technology

Small volumes of ATMPs: Safe handling of single-use bags

Cell and Gene therapies such as CAR T-cell therapy have proven their potential to become standard treatments to hard-to-treat diseases. Single Use Support has developed solutions for crucial challenges - read more!

michael-muehlegger

Michael Mühlegger

December 2, 2021

Cell & Gene Therapy

Small batch manufacturing & fill-finish in cell and gene therapy

A great example is the treatment of insidious cancers with CAR T-cells, that relies on modifying the patient’s own T-cells to instill them with a targeted way to fight cancer cells. Learn more why forming strong collaborations will solve many issues!

michael-muehlegger

Michael Mühlegger

October 10, 2022

Newsletter subscription

Get the latest delivered directly to your inbox!

Get the latest delivered directly to your inbox! You can unsubscribe at any time, no hard feelings. Privacy policy.